Texas 2021 - 87th Regular

Texas House Bill HB3137 Latest Draft

Bill / Introduced Version Filed 03/16/2021

                            By: Larson H.B. No. 3137


 A BILL TO BE ENTITLED
 AN ACT
 relating to a medical cannabis research program.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 481.062(a), Health and Safety Code, is
 amended to read as follows:
 (a)  The following persons may possess a controlled
 substance under this chapter without registering with the Federal
 Drug Enforcement Administration:
 (1)  an agent or employee of a manufacturer,
 distributor, analyzer, or dispenser of the controlled substance who
 is registered with the Federal Drug Enforcement Administration and
 acting in the usual course of business or employment;
 (2)  a common or contract carrier, a warehouseman, or
 an employee of a carrier or warehouseman whose possession of the
 controlled substance is in the usual course of business or
 employment;
 (3)  an ultimate user or a person in possession of the
 controlled substance under a lawful order of a practitioner or in
 lawful possession of the controlled substance if it is listed in
 Schedule V;
 (4)  an officer or employee of this state, another
 state, a political subdivision of this state or another state, or
 the United States who is lawfully engaged in the enforcement of a
 law relating to a controlled substance or drug or to a customs law
 and authorized to possess the controlled substance in the discharge
 of the person's official duties;
 (5)  if the substance is tetrahydrocannabinol or one of
 its derivatives:
 (A)  a Department of State Health Services
 official, a medical school researcher, or a research program
 participant possessing the substance as authorized under
 Subchapter G or G-1, including all persons permitted or otherwise
 authorized to possess cannabis under Subchapter G-1; or
 (B)  a practitioner or an ultimate user possessing
 the substance as a participant in a federally approved therapeutic
 research program that the commissioner has reviewed and found, in
 writing, to contain a medically responsible research protocol; or
 (6)  a dispensing organization licensed under Chapter
 487 that possesses low-THC cannabis.
 SECTION 2.  Chapter 481, Health and Safety Code, is amended
 by adding Subchapter G-1 to read as follows:
 SUBCHAPTER G-1. MEDICAL CANNABIS RESEARCH PROGRAM
 Sec. 481.251.  DEFINITION. In this subchapter, "commission"
 means the Health and Human Services Commission.
 Sec. 481.252.  MEDICAL CANNABIS RESEARCH PROGRAM. (a) Not
 later than January 31, 2022, the executive commissioner by rule
 shall establish a medical cannabis research program to be conducted
 by health-related institutions of higher education in this state.
 (b)  In adopting rules under this section, the executive
 commissioner may provide:
 (1)  procedures for a health-related institution of
 higher education in this state to apply to the commission for a
 permit to conduct medical cannabis research under the program
 established by this subchapter; and
 (2)  criteria for granting a permit to a health-related
 institution of higher education to conduct medical cannabis
 research.
 Sec. 481.253.  INSTITUTIONAL REVIEW BOARD. (a) Before
 applying for a permit under this subchapter, a health-related
 institution of higher education shall establish an institutional
 review board to review or approve the initiation of and conduct
 periodic review of research programs to ensure the legal protection
 of the rights and welfare of human research subjects.
 (b)  The institution may designate an existing board,
 committee, or other group as the institutional review board
 required under this section.
 Sec. 481.254.  COMPASSIONATE-USE RESEARCH. (a) A
 health-related institution of higher education may apply for a
 permit to research:
 (1)  the efficacy of medical cannabis product
 formulations and product forms;
 (2)  medical conditions that might benefit from
 treatment with medical cannabis and are approved by the
 health-related institution's institutional review board, including
 those not listed in Section 169.003, Occupations Code; and
 (3)  any other research matter approved by the
 institution's institutional review board.
 (b)  In applying for a permit, the health-related
 institution of higher education shall disclose any private sector
 organization contractors under Section 481.255 and shall disclose
 additional contractors as additional contractors are formed.
 Sec. 481.255.  CONTRACTORS. (a) A health-related
 institution of higher education granted a permit under this
 subchapter shall be authorized to contract with one or more private
 sector organizations to fulfill the terms of the permit, including
 contracting for the production and distribution of medical
 cannabis.
 (b)  A private sector organization is eligible to contract
 with a health-related institution of higher education under this
 subchapter if the organization:
 (1)  meets all requirements for a dispensing
 organization under Chapter 487, except that the participant is not
 required to pay a licensing or application fee;
 (2)  demonstrates capability to provide funding to
 support medical cannabis research activities at a health-related
 institution of higher education;
 (3)  demonstrates capability to establish and operate a
 production and distribution system sufficient to support research
 program needs; and
 (4)  is not a dispensing organization licensed under
 Chapter 487, owned or controlled by any direct or indirect owner of
 a licensed dispensing organization, or otherwise affiliated with a
 licensed dispensing organization.
 (c)  The commission shall approve contractors between
 health-related institutions of higher education and private sector
 organizations authorized under this subchapter.
 Sec. 481.256.  PATIENT TREATMENT. (a) Patient treatment
 provided as part of an approved research program under this
 subchapter may be administered only by a medical practitioner
 meeting standards approved by the institution's institutional
 review board.
 (b)  A patient participating in a research program under this
 subchapter must be a permanent resident of this state.
 Sec. 481.257.  INFORMED CONSENT. (a) Before receiving
 treatment under an approved research program, each patient must
 sign a written informed consent form.
 (b)  If a patient is a minor or lacks the mental capacity to
 provide informed consent, a parent, guardian, or conservator may
 provide informed consent on the patient's behalf.
 (c)  The executive commissioner shall adopt a form to be used
 for the informed consent required by this section.
 Sec. 481.258.  LICENSURE AS DISPENSING ORGANIZATION. A
 private sector organization contracting with a health-related
 institution of higher education under this subchapter shall be
 eligible for licensure as a dispensing organization under Chapter
 487, or any other law that authorizes cultivating, processing, and
 dispensing cannabis, on or after the second anniversary of the date
 the organization entered into a contract with a health-related
 institution of higher education related to a research program
 authorized under this subchapter, provided that the organization's
 operations comply with applicable state law.
 SECTION 3.  This Act takes effect September 1, 2021.